metastatic castration-resistant prostate cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
metastatic castration-resistant prostate cancer
May 19, 2024, 09:46 |
Blog
June 1 issue of ACS Journal Cancer
ACS Journal Cancer shared a post on X: “Read our June 1 issue! In this issue:…
May 8, 2024, 07:21 |
Insight
Umang Swami: Prior NHT in patients with MCRPC
Umang Swami, Assistant Professor in the Department of Oncology at Huntsman Cancer Institute, shared on…
Feb 29, 2024, 14:42 |
Insight
Researchers at Dana-Farber Cancer Institute and the University of Trento have developed a blood test that can reliably detect NEPC and differentiate it from CRPC-adenocarcinoma - Dana-Farber Cancer Institute
Jan 14, 2024, 14:49 |
Blog
Chris Boshoff: The European Medicines Agency approved our Prostate Cancer combination for men living with metastatic castration-resistant prostate cancer
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, shared on LinkedIn: "I’m proud…
All:
4
Posts:
1 - 100
TRANSiTION - Exclusive Train the Trainers Programme 2024
ASCO IDEA - Life-changing experience for the early-career oncologists in LMICs
Gemma Peters: The new government has an opportunity to fix our broken cancer care system
Blending Science and Compassion: Exclusive Conversation with ASCO President-Elect Eric J. Small
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Facebook
RSS Feed
Twitter
Linkedin
Youtube